Ignoring subtle body signals can be risky, as they might indicate serious health issues. Recurring headaches, easy bruising, unexplained weight loss, ...
A logical approach to investigating a case of muscle ‘aches and pains’ to rule out serious pathology and reach a diagnosis ...
The U.S. Food and Drug Administration (FDA) has approved its Guardant360® CDx as a companion diagnostic to identify patients ...
Onlymyhealth on MSN
Joint Pain in Your 20s and 30s? It Could Be Early Inflammatory Arthritis
Joint pain in your 20s or 30s could be early inflammatory arthritis Read ahead to know more about it as our expert explains ...
Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
MedPage Today on MSN
New Blood Test Rules Out Alzheimer's Disease
In May, the FDA cleared the first blood-based diagnostic test for Alzheimer's disease, the Lumipulse G pTau 217/β-Amyloid ...
Researchers from the University of East Anglia and biotechnology company Oxford Biodynamics have developed a new blood test for diagnosing ME/CFS with 96% accuracy.
New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...
The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.
Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an ...
The Elecsys pTau181 test is the second blood test cleared by the FDA this year for use in Alzheimer’s evaluation. In May, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results